Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Med Care. 2012 Dec;50(12):1053–1059. doi: 10.1097/MLR.0b013e318269e9c2

Table 3.

Subsequent use of mammography, ultrasound, biopsy/invasive procedures, or any follow-up in the years before and after introduction of digital mammography, overall and stratified by initial screening examination result.

Year Before Digital N (%) 1 Year After Digital N (%) 2 Years After Digital N (%) 3 Years After Digital N (%) 4 Years After Digital N (%)
All, N 8450 6327 6652 5522 3260
Mammography 827 (9.8) 830 (13.1) 923 (13.9) 597 (10.8) 275 (8.4)
Ultrasound 325 (3.8) 324 (5.1) 273 (4.1) 217 (3.9) 129 (4.0)
Biopsy 131 (1.6) 103 (1.6) 84 (1.3) 69 (1.2) 39 (1.2)
Any follow-up 947 (11.2) 936 (14.8) 1007 (15.1) 688 (12.5) 316 (9.7)
Negative*, N 7765 5590 5787 4837 3025
Mammography 318 (4.1) 249 (4.5) 413 (7.1) 208 (4.3) 70 (2.3)
Ultrasound 90 (1.2) 68 (1.2) 59 (1.0) 56 (1.2) 37 (1.2)
Biopsy 51 (0.7) 25 (0.4) 28 (0.5) 25 (0.5) 18 (0.6)
Any follow-up 384 (4.9) 294 (5.3) 453 (7.8) 257 (5.3) 101 (3.3)
False-positive or short interval follow-up*, N 595 674 695 528 229
Mammography 500 (84.0) 575 (85.3) 499 (71.8) 377 (71.4) 205 (89.5)
Ultrasound 231 (38.8) 254 (37.7) 211 (30.4) 160 (30.3) 92 (40.2)
Biopsy 78 (13.1) 76 (11.3) 54 (7.8) 43 (8.1) 21 (9.2)
Any follow-up 553 (92.9) 635 (94.2) 541 (77.8) 417 (79) 215 (93.9)
*

Mammograms with missing results or recommendations (1.4%) were excluded from analysis.